Log in

NASDAQ:CLXT - Calyxt Stock Price, Forecast & News

-0.16 (-2.61 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $5.97
50-Day Range
MA: $6.58
52-Week Range
Now: $5.97
Volume60,229 shs
Average Volume99,282 shs
Market Capitalization$196.71 million
P/E RatioN/A
Dividend YieldN/A
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for agriculture in the United States. It engages in the development of high oleic and low linolenic soybean product candidates; high fiber wheat; improved quality alfalfa product candidates; and cold storable and reduced browning potatoes. Read More…

Industry, Sector and Symbol

Industry Agricultural chemicals
SectorConsumer Staples
Current SymbolNASDAQ:CLXT



Sales & Book Value

Annual Sales$240,000.00
Book Value$2.87 per share


Net Income$-27,900,000.00
Net Margins-1,016.27%


Market Cap$196.71 million
Next Earnings Date3/5/2020 (Confirmed)
OptionableNot Optionable

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) issued its quarterly earnings results on Wednesday, November, 6th. The company reported ($0.32) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.31) by $0.01. The company earned $2.97 million during the quarter. Calyxt had a negative net margin of 1,016.27% and a negative return on equity of 43.09%. View Calyxt's Earnings History.

When is Calyxt's next earnings date?

Calyxt is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Calyxt.

How can I listen to Calyxt's earnings call?

Calyxt will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for CLXT?

3 brokers have issued 12 month price objectives for Calyxt's shares. Their forecasts range from $15.00 to $16.00. On average, they expect Calyxt's stock price to reach $15.67 in the next twelve months. This suggests a possible upside of 162.4% from the stock's current price. View Analyst Price Targets for Calyxt.

What is the consensus analysts' recommendation for Calyxt?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Calyxt.

What are Wall Street analysts saying about Calyxt stock?

Here are some recent quotes from research analysts about Calyxt stock:
  • 1. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (1/3/2020)
  • 2. National Securities analysts commented, " Second Quarter Shows Progress And Growing Pains. With low and lumpy volumes in its first
    year of commercialization and weather issues reducing planted acreage from prior estimates,
    CLXT’s second quarter brought a degree of near term revenue uncertainty. OpEx also moved up
    sequentially more than we estimated. While a modest disappointment, we consider the
    improvement in distribution network and the market acceptance of the lead product to be
    encouraging and far more important to the value proposition.
     Customer Adoption Accelerates. With 20 customers currently, up from low single digits since
    the first quarter, we believe the market for both oil and meal is strong. As the company builds
    scale, we do not believe securing customers will be a meaningful hurdle. The next major bar is
    securing from consumer goods customers, which we expect over the next twelve months.
     Guilt By Association. Unwinnable tariff wars and weather challenges have dragged down Ag
    stocks this year. We believe CLXT is less exposed to these issues and can actually benefit from
    weak markets given its differentiated product offering in a commoditized space, yet the stock has
    underperformed its peers with more exposure to these variables.
     Lower Price Target, But Deep Value Opportunity. We believe the declines of 66% from its YTD
    high, and 32% in the past seven trading days alone are not justified and put the stock in deep
    value territory. Our lower price target is a reflection of adjustments to our model and assumed
    multiple, not a reflection of the value proposition which we believe remains significant." (8/8/2019)

Has Calyxt been receiving favorable news coverage?

News headlines about CLXT stock have been trending somewhat positive recently, according to InfoTrie. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Calyxt earned a news impact score of 0.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Calyxt.

Are investors shorting Calyxt?

Calyxt saw a decline in short interest in January. As of January 15th, there was short interest totalling 573,900 shares, a decline of 24.7% from the December 31st total of 761,800 shares. Based on an average trading volume of 184,800 shares, the days-to-cover ratio is presently 3.1 days. Currently, 5.7% of the shares of the stock are short sold. View Calyxt's Current Options Chain.

Who are some of Calyxt's key competitors?

What other stocks do shareholders of Calyxt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calyxt investors own include Cellectis (CLLS), Cypress Semiconductor (CY), Molecular Templates (MTEM), Netflix (NFLX), Secureworks (SCWX), AbbVie (ABBV), Eaton (ETN), Pure Storage (PSTG), Advanced Micro Devices (AMD) and Arena Pharmaceuticals (ARNA).

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Mr. James A. Blome, Chief Exec. Officer (Age 56)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 56)
  • Mr. Manoj Sahoo, Chief Commercial Officer (Age 44)
  • Mr. William F. Koschak, Chief Financial Officer (Age 50)
  • Mr. Eric Dutang, Principal Accounting Officer (Age 45)

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities acted as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (11.78%), Nikko Asset Management Americas Inc. (1.71%), Sumitomo Mitsui Trust Holdings Inc. (1.71%), Columbus Hill Capital Management L.P. (1.31%), Mairs & Power INC (0.67%) and State Street Corp (0.46%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, James Blome, Manoj Sahoo, Michel Arbadji, Philippe Dumont, SA Cellectis, Travis Frey and Yves J Ribeill. View Institutional Ownership Trends for Calyxt.

Which major investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Columbus Hill Capital Management L.P. and Bank of New York Mellon Corp. Company insiders that have sold Calyxt company stock in the last year include Daniel F Voytas, James Blome, Manoj Sahoo, Philippe Dumont and Yves J Ribeill. View Insider Buying and Selling for Calyxt.

Which major investors are buying Calyxt stock?

CLXT stock was bought by a variety of institutional investors in the last quarter, including Essex Investment Management Co. LLC, Renaissance Technologies LLC, Windsor Creek Advisors LLC, KBC Group NV, State Street Corp, Mairs & Power INC, Rhumbline Advisers and Barclays PLC. Company insiders that have bought Calyxt stock in the last two years include SA Cellectis and Travis Frey. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $5.97.

How big of a company is Calyxt?

Calyxt has a market capitalization of $196.71 million and generates $240,000.00 in revenue each year. The company earns $-27,900,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Calyxt employs 50 workers across the globe.View Additional Information About Calyxt.

What is Calyxt's official website?

The official website for Calyxt is http://www.calyxt.com/.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]

MarketBeat Community Rating for Calyxt (NASDAQ CLXT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  233 (Vote Outperform)
Underperform Votes:  231 (Vote Underperform)
Total Votes:  464
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Trading Ex-Dividend

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel